Verastem Adds Another FDA Fast Track as it Targets a Hard to Treat Lung CancerBusiness PenJune 5, 2026 June 5, 2026 [stock_market_widget type=”card” template=”basic2″ assets=”VSTM” realtime=”true” api=”yahoo-finance”] Verastem Oncology, Inc. (NASDAQ: VSTM) has added another regulatory milestone for VS 7375, a drug still in early testing...
